123 related articles for article (PubMed ID: 9853986)
1. Comparison of four immunoassays for the detection of lorazepam in urine.
Meatherall R; Fraser AD
Ther Drug Monit; 1998 Dec; 20(6):673-5. PubMed ID: 9853986
[TBL] [Abstract][Full Text] [Related]
2. CEDIA dau Benzodiazepine screening assay: a reformulation.
Meatherall RC; Fraser AD
J Anal Toxicol; 1998; 22(4):270-3. PubMed ID: 9681328
[TBL] [Abstract][Full Text] [Related]
3. Benzodiazepine screening using EMIT II and TDx: urine hydrolysis pretreatment required.
Meatherall R
J Anal Toxicol; 1994; 18(7):385-90. PubMed ID: 7861751
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of five immunoassays for the analysis of alprazolam and triazolam metabolites in urine: effect of lowering the screening and GC-MS cut-off values.
Fraser AD; Meatherall R
J Anal Toxicol; 1996; 20(4):217-23. PubMed ID: 8835658
[TBL] [Abstract][Full Text] [Related]
5. Detection of benzodiazepine intake in therapeutic doses by immunoanalysis of urine: two techniques evaluated and modified for improved performance.
Beck O; Lafolie P; Hjemdahl P; Borg S; Odelius G; Wirbing P
Clin Chem; 1992 Feb; 38(2):271-5. PubMed ID: 1541010
[TBL] [Abstract][Full Text] [Related]
6. Oxaprozin cross-reactivity in three commercial immunoassays for benzodiazepines in urine.
Fraser AD; Howell P
J Anal Toxicol; 1998; 22(1):50-4. PubMed ID: 9491969
[TBL] [Abstract][Full Text] [Related]
7. The online screening technique for urinary benzodiazepines: comparison with EMIT, FPIA, and GC-MS.
Beck O; Lin Z; Brodin K; Borg S; Hjemdahl P
J Anal Toxicol; 1997; 21(7):554-7. PubMed ID: 9399125
[TBL] [Abstract][Full Text] [Related]
8. Urine benzodiazepine screening using Roche Online KIMS immunoassay with beta-glucuronidase hydrolysis and confirmation by gas chromatography- mass spectrometry.
Klette KL; Wiegand RF; Horn CK; Stout PR; Magluilo J
J Anal Toxicol; 2005 Apr; 29(3):193-200. PubMed ID: 15842763
[TBL] [Abstract][Full Text] [Related]
9. KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic pain.
Darragh A; Snyder ML; Ptolemy AS; Melanson S
Pain Physician; 2014; 17(4):359-66. PubMed ID: 25054395
[TBL] [Abstract][Full Text] [Related]
10. Improved cross-reactivity to alpha OH triazolam in the BMC CEDIA DAU urine benzodiazepine assay.
Fraser AD; Meatherall R
Ther Drug Monit; 1998 Jun; 20(3):331-4. PubMed ID: 9631932
[TBL] [Abstract][Full Text] [Related]
11. Comparison between the CEDIA and EMIT II immunoassays for the determination of benzodiazepines.
Way BA; Walton KG; Koenig JW; Eveland BJ; Scott MG
Clin Chim Acta; 1998 Mar; 271(1):1-9. PubMed ID: 9564553
[TBL] [Abstract][Full Text] [Related]
12. Enzyme immunoassay, kinetic microparticle immunoassay, radioimmunoassay, and fluorescence polarization immunoassay compared for drugs-of-abuse screening.
Armbruster DA; Schwarzhoff RH; Hubster EC; Liserio MK
Clin Chem; 1993 Oct; 39(10):2137-46. PubMed ID: 8403399
[TBL] [Abstract][Full Text] [Related]
13. Comparison of EMIT II, CEDIA, and DPC RIA assays for the detection of lysergic acid diethylamide in forensic urine samples.
Wiegand RF; Klette KL; Stout PR; Gehlhausen JM
J Anal Toxicol; 2002 Oct; 26(7):519-23. PubMed ID: 12423010
[TBL] [Abstract][Full Text] [Related]
14. Cloned enzyme donor immunoassay (CEDIA) for drugs-of-abuse screening.
Armbruster DA; Hubster EC; Kaufman MS; Ramon MK
Clin Chem; 1995 Jan; 41(1):92-8. PubMed ID: 7813088
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the rates of hydrolysis of lorazepam-glucuronide, oxazepam-glucuronide and tamazepam-glucuronide catalyzed by E. coli beta-D-glucuronidase using the on-line benzodiazepine screening immunoassay on the Roche/Hitachi 917 analyzer.
Dou C; Bournique JS; Zinda MK; Gnezda M; McNally AJ; Salamone SJ
J Forensic Sci; 2001 Mar; 46(2):335-40. PubMed ID: 11305436
[TBL] [Abstract][Full Text] [Related]
16. Comparison of several immunoassays used in drugs of abuse screening: Assessment against gold standard methods and calculation of measurement uncertainty.
Mina A
J Pharmacol Toxicol Methods; 2020; 101():106649. PubMed ID: 31730939
[TBL] [Abstract][Full Text] [Related]
17. Identification of urinary benzodiazepines and their metabolites: comparison of automated HPLC and GC-MS after immunoassay screening of clinical specimens.
Valentine JL; Middleton R; Sparks C
J Anal Toxicol; 1996 Oct; 20(6):416-24. PubMed ID: 8889678
[TBL] [Abstract][Full Text] [Related]
18. The determination of drugs of abuse in whole blood by means of FPIA and EMIT-dau immunoassays--a comparative study.
Bogusz M; Aderjan R; Schmitt G; Nadler E; Neureither B
Forensic Sci Int; 1990 Nov; 48(1):27-37. PubMed ID: 2279719
[TBL] [Abstract][Full Text] [Related]
19. Comparison of assay methods for benzodiazepines in urine. A receptor assay, two immunoassays, and gas chromatography-mass spectrometry.
Nishikawa T; Ohtani H; Herold DA; Fitzgerald RL
Am J Clin Pathol; 1997 Mar; 107(3):345-52. PubMed ID: 9052386
[TBL] [Abstract][Full Text] [Related]
20. Comparison of methaqualone excretion patterns using Abuscreen ONLINE and EMIT II immunoassays and GC/MS.
Brenner C; Hui R; Passarelli J; Wu R; Brenneisen R; Bracher K; ElSohly MA; Ghodoussi VD; Salamone SJ
Forensic Sci Int; 1996 May; 79(1):31-41. PubMed ID: 8635771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
